Chloramphenicolum

Chloramphenicol; IUPAC: 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide. Formerly trade-named Chloromycetin. · Chloramphenicol, Chloromycetin, Chloramphenicolum (homeopathic Latin)

Modern MM

A modern "synthetic-drug" remedy whose recorded sphere of action centres on the blood and bone marrow (anaemia, agranulocytosis, aplasia), the optic/peripheral nerves and the neonate — mirroring the well-documented toxicology of the parent antibiotic. A proving/clinical study was catalogued by O. A. Julian (1988); the bulk of accessible indications remain toxicologically derived.

Key symptoms

Indications are inferred chiefly from chloramphenicol's toxicology under the Law of Similars: states of blood and bone-marrow depression — aplastic anaemia, agranulocytosis, pancytopenia, thrombocytopenia; convalescence with profound anaemia and prostration following drug or infectious exposure. Neonatal/infant collapse states recalling "gray baby syndrome" — ashen-grey pallor with cyanosis, abdominal distension, vomiting, hypothermia, irregular respiration, vasomotor collapse. Optic and peripheral neuritis with dimness of vision. Accompanying neuropsychiatric features documented for the drug: headache, mental confusion, mild depression, delirium. These are characteristic-indication summaries drawn from toxicology, not verified proving keynotes.

Worse (aggravation)

Not reliably established. No well-documented proving modalities are available in accessible sources; none are asserted here to avoid fabrication.

Better (amelioration)

Not reliably established in accessible sources; none asserted.

Manohar V Nagaiah

Materia Medica of Modern Homeopathic Medicine · 2026

Chloramphenicol, Chloromycetin, Chloramphenicolum (homeopathic Latin)

Source & Nature

CHLORAMPHENICOLUM is prepared from chloramphenicol, a broad-spectrum amphenicol antibiotic (C11H12Cl2N2O5, molecular weight 323.13 g/mol, CAS 56-75-7, PubChem CID 5959). The drug was first isolated in 1947 from the soil bacterium Streptomyces venezuelae and was first chemically synthesized in 1949. Homeopathic pharmacies classify it as a "substance" remedy under the source organism Streptomyces venezuelae (family Streptomycetaceae). Pharmacologically it is bacteriostatic, inhibiting bacterial protein synthesis at the 50S ribosomal subunit.

Preparation

Made by standard homeopathic trituration of the chloramphenicol substance with lactose/saccharose to soluble centesimal stages, then serial dilution and succussion in ethanol/water. Remedia offers hand-made globules in C6, C7, C9, C10, C12, C15, C30, C60, C100 and C200, liquid dilutions C30-C200, and a 1MK (Korsakovian) potency; it is also listed by Helios, Ainsworths, Freeman's and Zinsser.

Continue Modern MM in the app

Classical texts are in the public domain. Educational reference only — not medical advice.